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Abstract
Background: Prognostic factors in malignant melanoma are currently based on clinical data and morphologic 
examination. Other prognostic features, however, which are not yet used in daily practice, might add important 
information and thus improve prognosis, treatment, and survival. Therefore a search for new markers is desirable. 
Previous studies have demonstrated that fractal characteristics of nuclear chromatin are of prognostic importance in 
neoplasias. We have therefore investigated whether the fractal dimension of nuclear chromatin measured in routine 
histological preparations of malignant melanomas could be a prognostic factor for survival.
Methods: We examined 71 primary superficial spreading cutaneous melanoma specimens (thickness ≥ 1 mm) from 
patients with a minimum follow up of 5 years. Nuclear area, form factor and fractal dimension of chromatin texture 
were obtained from digitalized images of hematoxylin-eosin stained tissue micro array sections. Clark's level, tumor 
thickness and mitotic rate were also determined.
Results: The median follow-up was 104 months. Tumor thickness, Clark's level, mitotic rate, nuclear area and fractal 
dimension were significant risk factors in univariate Cox regressions. In the multivariate Cox regression, stratified for the 
presence or absence of metastases at diagnosis, only the Clark level and fractal dimension of the nuclear chromatin 
were included as independent prognostic factors in the final regression model.
Conclusion: In general, a more aggressive behaviour is usually found in genetically unstable neoplasias with a higher 
number of genetic or epigenetic changes, which on the other hand, provoke a more complex chromatin 
rearrangement. The increased nuclear fractal dimension found in the more aggressive melanomas is the mathematical 
equivalent of a higher complexity of the chromatin architecture. So, there is strong evidence that the fractal dimension 
of the nuclear chromatin texture is a new and promising variable in prognostic models of malignant melanomas.
Background
Malignant melanoma is a highly aggressive neoplasia of
the skin with a constant and rapidly increasing incidence
in the last decades [1] Prognostic factors are currently
based on clinical data and morphologic examination
(including variables such as tumor thickness, mitotic rate,
etc.) [1-3], which are reliable and reproducible. Other
prognostic markers, however, which are not yet used in
daily practice, might add important information and thus
improve prognosis, treatment, and survival. Therefore a
search for new prognostic factors is desirable. For this
purpose, traditional or new immunohistochemical mark-
ers, gene expression arrays, comparative genomic hybrid-
ization and mutational profiling have been applied [1,4-
9]. Most of these techniques are sophisticated and expen-
sive, requiring specially equipped laboratories with a
trained staff, Detailed morphological analysis of the
nuclei in histological or cytological preparations can give
important information on cell physiology and, further-
more, can be of considerable great diagnostic and prog-
nostic importance [10-22]. Physiologic or pathologic
changes of the cell accompany changes of the chromatin
arrangement [21,22]. In particular, neoplastic growth
induces important modifications, not only of the DNA,
but also of the composition and distribution of the his-
tone and non-histone nuclear proteins, thus provoking
alterations of the distribution of heterochromatin in the
nucleus. Nuclear texture features have been studied as
prognostic markers in neoplasias [11,21,22]. The
resources available in commercial softwares are usually
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Page 2 of 6restricted to basic morphometric parameters such as
diameter, area and perimeter, which cannot adequately
measure texture features of nuclei.
An important aspect of texture analysis is the determi-
nation of fractality, since this feature characterizes the
complexity of a structure not revealed by classical mor-
phometry based on Euclidean geometry. Recent studies
have shown the fractal nature of nuclear chromatin and
of the surrounding nucleoplasmic space [23-25]. Fractals
are self-similar structures, i.e. they exhibit similar fea-
tures at different magnifications, in a scale-invariant
manner. Previous studies have shown that fractal charac-
teristics of nuclear chromatin are of prognostic impor-
tance in neoplasias [21,26-29]. Therefore we have
investigated whether the fractal dimension of nuclear
chromatin measured in routinely stained histological
preparations of melanomas can be of prognostic survival
value.
Methods
Study subjects
Patients who had superficial spreading cutaneous mela-
noma, diagnosed and treated at the Hospital AC Cama-
rgo, Center for Cancer Research and Treatment between
1994 and 2000 were examined. The study was approved
by the local ethics committee (CONEP - 119149, 13th of
December 2006.) Inclusion criteria were: 1. tumor size ≥
1 mm; 2. paraffin blocks available for the construction of
the tissue microarray; 3. detailed and complete clinical
follow-up for at least 60 months in survivors. and 4. clini-
cal information about the cause of death in non-survi-
vors. All cases were reviewed according to the protocol
established by the Brazilian Melanoma Group and the
Brazilian Society of Pathology by a dermatopathologist
(GL). The following histological variables were assessed:
tumor thickness, Clark's level and mitotic rate (number of
mitoses/mm2). Two core biopsies were obtained from
paraffin-embedded tissue of each tumor within the previ-
ously identified and marked area. Using a Tissue
Microarrayer (Beecher Instruments, Silver Spring, USA ™
) with a sample needle of 1.0 mm, the tissue cores were
transferred to a recipient paraffin block, according to the
technique of Kononen et al [30]. A 6 μm section of the
master block was stained with haematoxylin-eosin
(H&E).
Data collection
Image acquisition was performed with a Leica DC 500 ™
digital camera with high resolution (12 megapixels), and
an oil immersion objective (x100). The images were saved
without compression in bitmap format 24-bit color. At
least 100 randomly selected tumor nuclei were acquired
per case by the same operator. Only non overlapping
nuclei with characteristics of melanoma cells were cap-
tured, interactively segmented and then converted to a 8
bit gray scale by calculating the luminance.
Finally we measured, as morphometric parameters of
each nucleus, the nuclear area and the circular form fac-
tor. The latter represents the ratio between perimeter of a
circle with the same area as the nucleus and the actual
nuclear perimeter. The fractal dimension of the chroma-
tin was calculated in accordance with Sarkar [31]. After
normalization of the gray value histogram for each
nucleus, a pseudo-three-dimensional image was created
with the z axis defined by the gray level of each pixel, thus
transforming the hematoxylin-stained chromatin texture
into a rough surface (Fig1A, B). The fractal dimension
(FD) of the surface of the normalized pseudo 3-D images
was calculated with a software developed in house by our
group. The space was filled with cubes and the number of
intersections with the irregular landscape-like surface
counted. This procedure was repeated with smaller or
larger cubes. In a log-log (Fig 1C) diagram for each of
these procedures, the number of intersections was plot-
ted against the size of the cubes. The fractal dimension
could be obtained by the slope of the linear regression
line (Fig 1C). The goodness of fit of the regression line
was estimated by the R2 value of the regression between
the real and the estimated values [32]. Furthermore, we
tested with the Kolmogorov-Smirnov test, whether the
residuals followed a normal distribution calculating for
each patient the percentage of cells with normally distrib-
uted residuals.
Statistical Analysis
Correlations between variables were calculated according
to Pearson's method after testing for normal distribution
with the Kolmogorov-Smirnov test. Melanoma specific
survival was calculated with Cox regressions. Patient
death not related to melanoma was censored. All vari-
ables with p ≤ 0.05 in the univariate Cox regressions were
included in a multivariate proportional hazard model (p
= 0.05 for input and p = = 0.1 for output, forward condi-
tional step-wise selection) in order to get a prognostic
model. Categorization of subgroups was not possible in
the multivariate Cox model when there were no events in
at least one of them, because, in this case, the regression
did not converge. When this was the case, we defined
each category by its quotient calculated between
observed and expected events in the log-rank test of the
corresponding Kaplan-Meier model, as suggested earlier
[33].
Results
The study involved 41 women and 30 men. The median
follow-up was 104 months (8 -160). Fifteen patients died
from disseminated disease. Primary tumors were located
in the trunk in 47.1% patients, 44.1% in the extremities,
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ing 1.05 -17.0 mm (median 2.35 mm), was a significant
adverse prognostic factor in the univariate Cox regression
( B = 0.1623; p = 0.0007). The Clark level ranged from 2 to
5, and was also a significant adverse prognostic factor ( B
= 1.1574; p = 0.0011). At diagnosis, patients had a median
age of 55 years (14-89). Age was not a prognostic factor in
the univariate proportional hazard model (p > 0.10).
Eight patients had lymph node metastases and 3 patients
hematogenic metastases at diagnosis, but their survival
was not statistically worse (p > 0.1 in both cases). The
median mitotic rate was 1.875/mm2 (0-32.5/mm2). The
mitotic rate was significantly correlated with tumor
thickness (r = 0.54; p < 0.0001) and revealed to be a nega-
tive prognostic factor (B = 0.0744. p = 0.007). The nuclear
area (median value: 81.3 micra²; range 33.7 to 139.3) was
also correlated both with the tumor thickness (r = 0.405;
p = 0.00045) and the mitotic rate (r = 0.31; p = 0.008), and
was a significant unfavorable prognostic factor (B =
0.0212; p = 0.0274).The form factor (median: 0.706 rang-
ing from 0.57.3-0.807) was negatively correlated with
tumor thickness (r = -0.431; p < 0.0001 ) and mitotic rate
(r = -0.28; p = 0.016), but was of no prognostic relevance
(p = 0.417). The fractal dimension of the chromatin struc-
ture ranged from 2.01 to 2.082 with a median of 2.06. The
median of the R2 values, which represent the goodness-
of-fit of the regression lines, was 0.9998 (range 0.9989 -
0.9999). In each case, between 96% and 100% of the
nuclei revealed normal distribution of the residuals. The
fractal dimension was significantly correlated both with
tumor thickness (r = 0.482; p < 0.0001) and the mitotic
rate (r = 0.342; p = 0.002) and was a negative prognostic
factor for survival (B = 73.9; p = 0.0091). We also ran a
multivariate Cox regression, stratified for the presence or
absence of metastases at diagnosis, and including all vari-
ables with p < 0.05 in the univariate models. The final
regression included only Clark level (B = 1.0427; p =
0.0036) and fractal dimension of the chromatin (B =
55.169; p = 0.05) as independent prognostic factors.
Discussion
The relevance of tumor thickness, Clark's level and the
mitotic rate, which are well known prognostic factors in
the literature [1,2,34], were confirmed in this study. But
we could not demonstrate the presence of lymph node or
hematogenic metastases as significant prognostic factors.
This is certainly due to the very small number of patients
with stage III or IV, so that the statistical test power was
too low to show significant differences. Nevertheless, to
eliminate even minor influences of metastases on the
proportional hazard model, we stratified the Cox regres-
sion for the presence of metastases. The main emphasis
of our investigation was to test karyometic variables
being as prognostic factors.
The use of computerized image analysis has contrib-
uted to an objective description of melanoma cells and
decreased substantially inter-observer variation. Objec-
tive measurement of nucleolar organizer regions
(AgNORs), proliferating cell nuclear antigen (PCNA) and
Ki-67, nuclear DNA content or karyometric variables
such as chromatin compactness, and nuclear size and
shape, have been used for differential diagnosis between
melanomas and several forms of melanocytic nevi [35-
37].
Karyometric differences between benign and malignant
melanocytic lesions reflect alterations at the genetic and
Figure 1 a) segmented nucleus b) pseudo-three-dimensional image, and c) log-log  diagram.
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melanocytic nevi to dysplastic nevi to melanoma. This
process involves dynamic changes in the genome pro-
duced by mutations through gain of oncogene function or
loss of action of tumor suppressor genes. But many addi-
tional alterations of gene expression can be found during
tumor progression, passing from the radial to the vertical
growth phase and finally to the metastatic phenotype [1].
Abnormalities in mitotic regulators such as RASSF1A
and Aurora kinases promote chromosomal instability on
melanoma cells [38]. Comparative genomic hybridization
revealed a higher number of genetic alterations in pri-
mary melanomas which developed metastases within one
year after surgery compared to tumors that did not
metastasize [39]. Thus the aggressive behavior of mela-
noma seems to be associated with an accumulation of
multiple genetic alterations.
The nucleus is organized at three hierarchical levels:
the organization of nuclear processes, the higher-order
organization of the chromatin fiber, and the spatial
arrangement of genomes within the nuclear space. Struc-
ture and function interact mutually in a dynamic way.
There is increasing evidence for self-organization of
nuclear architecture and function at all levels of organiza-
tion leading to a high degree of structural complexity in
the mammalian cell nucleus [40]. Chromatin is separated
into two distinct conformations: euchromatin, which is
uncondensed and the much denser heterochromatin,
which is considered to be transcriptionally less active.
Recent investigations are challenging this concept, dem-
onstrating that chromatin structure is correlated with
gene density, rather than activity. According to them,
decondensed chromatin is representing gene-rich and
condensed chromatin gene-poor regions [41]. Mascolo et
al [42] demonstrated that overexperession of the chroma-
tin assembly factor-1 which promotes histone incorpora-
tion into chromatin, was associatied with a higher risk to
develop metastases. Based on these studies we may
hypothesize that the chromatin organization of aggres-
sive melanomas with an increased number of genetic and
epigenetic alterations should be different from those with
a more benign clinical course. The characteristics of the
nuclear architecture, as seen by the pathologist in routine
sections, reflect genomic and non-genomic changes in
both the structure of DNA and chromatin [43]. Taking
together all these studies, we may expect that changes of
nuclear shape, size and chromatin texture would accom-
pany tumor progression and the transformation to a
more aggressive phenotype.
Our karyometric measurements corroborate this
hypothesis. With increasing tumor thickness, i.e. vertical
growth, the nuclear area enlarged and the form factor
decreased, i.e. the nuclei tended to loose their rounded-
ness. In the univariate Cox regression, nuclear area was
also a significantly negative prognostic factor, i.e., the
ability to metastasize was higher in melanomas with
larger nuclei. This result confirms a previous study, which
showed that the mean nuclear volume of primary mela-
nomas with subsequent metastatic course was larger than
tumors that did not metastatize [44]. Talve et al [45]
observed in aneuploid melanomas a correlation of tumor
thickness with nuclear size and increased genetic instabil-
ity. The nuclear size in our investigation was also posi-
tively correlated with the fractal dimension of the
chromatin architecture of the nuclei.
The fractal concept of self-similar structures was intro-
duced by Mandelbrot [46]. Paumgartner et al. [47]
applied it to microscopic images in biology and medicine.
Grosberg et al [48] postulated that folded polymers
should be fractals. During condensation, a polymer is
repeatedly subjected to the self-similar process of crum-
pling, and this applies also to chromatin. Thus, the con-
densed polymer becomes finally a fractal. In that way a
long polymer can be packed in a small volume without
entanglements, which facilitates unravelling when neces-
sary and is therefore an advantage for cell physiology [49].
Recent experimental studies showed indirect evidence for
the fractal nature of DNA, nuclear chromatin and the
surrounding nucleoplasmic space [23-25]. Our results
gave evidence for the fractal nature of nuclear chromatin
stained by haematoxylin in paraffin sections of melanoma
cells.
The question whether a given structure should be con-
sidered as fractal, is linked not only to its scaling charac-
teristics, which follow power laws. The goodness-of fit of
the linear regression in the log-log plot is essential. The
observed values should lie as close as possible on the
straight regression line, where the slope gives an estimate
of the fractal dimension. This condition was fulfilled
since the R2 values of the regression were allways > 0.99.
Moreover, the histograms of the residuals, which are scat-
tered around this line should follow a normal distribution
[21,32,50]. In our study, between 96% and 100% of the
nuclei per case had Gaussian distribution of the residuals.
Therefore we are authorized to apply the concept of frac-
tality and calculate the fractal dimension.
We are measuring the fractal dimension of a rough and
irregular surface, The dimension of a plane surface is 2
and that of a cube 3. In an intuitive way one can interpret
the fractal dimension of a rough, "landscape-like" surface
as being in between the dimensions of a plane and of the
cube, therefore 2 < FD < 3. The fractal dimension is
equivalent to the slope of the regression line which
depends on the number of intercepts of the surface with
the boxes. A "smoother" surface has less intercepts and
therefore a lower FD than a "rougher" surface. The fractal
dimension was an independent adverse prognostic factor
for survival in malignant melanomas. In other words,
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A more aggressive behaviour is usually found in geneti-
cally unstable neoplasias with a higher number of genetic
or epigenetic changes, which provoke a more complex
chromatin rearrangement, revealing an increased num-
ber of darker and lighter areas.
Previous studies demonstrated an association between
higher FD values of the nucleus and worse prognosis in
multiple myelomas [29], squamous cell carcinomas of the
oral cavity [26] and in squamous cell carcinomas of the
larynx [28].
Tumor thickness, nuclear size, mitotic index and fractal
dimension have all been positively correlated with each
other in this study. Nevertheless, the stepwise procedure
in the multivariate Cox regression selected the fractal
dimension and the Clark level as independent variables
that built up the best proportional hazard model explain-
ing patients' survival. This implies that the complexity of
chromatin distribution contains relevant prognostic
information which is independent of the Clark level.
Since this investigation was based on a relatively small
number of patients, it should be followed by confirmatory
studies.
Conclusion
Our study showed that the chromatin texture of hema-
toxylin-eosin stained nuclei in paraffin sections of mela-
noma cells can be described as a fractal. The increased
nuclear fractal dimension found in the more aggressive
melanomas is the mathematical equivalent of a greater
complexity of their chromatin architecture. We conclude
that there is strong evidence that the fractal dimension of
the nuclear chromatin texture is a new and promising
variable in prognostic models of malignant melanomas.
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